Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

37.40
-0.2000-0.53%
Post-market: 37.34-0.0600-0.16%19:30 EDT
Volume:1.60M
Turnover:59.67M
Market Cap:5.03B
PE:-10.74
High:38.14
Open:37.70
Low:36.86
Close:37.60
52wk High:49.70
52wk Low:10.46
Shares:134.37M
Float Shares:129.97M
Volume Ratio:0.66
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4823
EPS(LYR):-2.0600
ROE:-64.09%
ROA:-20.64%
PB:5.47
PE(LYR):-18.16

Loading ...

Definium Therapeutics Issues Inducement Stock Options for 334,810 Shares to New Hires

Reuters
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)

TIPRANKS
·
Sep 19

Definium Therapeutics Issues Inducement Stock Options to New Hires

TIPRANKS
·
Sep 17

Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety

TIPRANKS
·
Sep 17

China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales

Reuters
·
Sep 16

Stifel Nicolaus Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)

TIPRANKS
·
Sep 16

Definium Therapeutics is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Sep 15

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

Reuters
·
Sep 15

UK's ImmuPharma Interim Net Loss Widens on Derivative Finance Loss

Reuters
·
Sep 15

UK's ValiRx Half-Year Loss Narrows, Cash Position Improves

Reuters
·
Sep 15

Kestra Medical Technologies Q1 Revenue Beats Estimates, Raises FY Revenue Outlook

Reuters
·
Sep 15

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

Reuters
·
Sep 15

Definium Therapeutics price target raised to $91 from $75 at BofA

TIPRANKS
·
Sep 15

FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

Reuters
·
Sep 15

Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)

TIPRANKS
·
Sep 15

Top Midday Stories: No OpenAI IPO in 2026, Altman Reportedly Says; Nvidia, Palantir Said to Restrict AI Usage Over Customer Data Fears

MT Newswires Live
·
Sep 14

First Marijuana, Then Peptides. Why Psychedelics are Wall Street's Next Big Trip.

Dow Jones
·
Sep 14

Definium Therapeutics Inc : Leerink Partners Raises Target Price to $70 from $52

THOMSON REUTERS
·
Sep 14

Definium Therapeutics Price Target Maintained with a $66.00/Share by Needham

Dow Jones
·
Sep 14

Definium Therapeutics Shares Gain After Reporting Positive Results in Anxiety Study

Dow Jones
·
Sep 14